Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $137.70 | Total: $688.50 |
| 1 | 10 | $116.64 | Total: $1,166.40 |
| 1 | 25 | $98.82 | Total: $2,470.50 |
| 1 | 50 | $84.24 | Total: $4,212.00 |
| 1 | 100 | $72.90 | Total: $7,290.00 |
Overview
Zanoterone is an AR antagonist (androgen receptor).Zanoterone has antitumor activity for the treatment of genitourinary disorders and oncological disorders and may be used in the study of prostate cancer.
Chemical Properties
| Molecular Formula | C23H32N2O3S |
| Molecular Weight | 416.58 |
| CAS Numbers | 107000-34-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@](C#C)(O)CC4)[H])(CC[C@]1(CC=5C(C2)=CN(S(C)(=O)=O)N5)[H])[H])[H] |
Storage and Handling
0C Short Term, -20C Long Term
References
Juniewicz PE, et al. Effect of combination treatment with zanoterone [WIN 49596], a steroidal androgen receptor antagonist, and finasteride [MK-906], a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs. Endocrinology. 1993;133[2] 904-913.